×
About 5,759 results

ALLMedicine™ Nasal Polyps Center

Research & Reviews  2,753 results

Microbiome profiling of uncinate tissue and nasal polyps in patients with chronic rhino...
https://doi.org/10.1371/journal.pone.0249688
PloS One; Cho SW, Kim DY et. al.

Apr 8th, 2021 - Chronic rhinosinusitis (CRS) is characterized according to the presence or absence of nasal polyps (NPs) and displays nasal microbiota dysbiosis. However, optimal sampling methods of the nasal microbiome in CRS have not been identified. We aimed t...

Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis.
https://doi.org/10.4193/Rhin20.649
Rhinology Seresirikachorn K, Kerr SJ et. al.

Apr 6th, 2021 - Low-dose macrolides (LDM) are anti-inflammatory agents with antineutrophilic activity, but patient selection for LDM therapy in treating chronic rhinosinusitis (CRS) is controversial. This study aimed to assess factors which predict LDM responders...

British Rhinological Society Consensus Guidance on the use of biological therapies for ...
https://doi.org/10.1111/coa.13779
Clinical Otolaryngology : Official Journal of ENT-UK ; Of... Hopkins C, McKenzie JL et. al.

Apr 5th, 2021 - We set out to create Consensus Guidelines, based on current evidence and relative risks of adverse effects and the costs of different treatments, that reflect the views of the British Rhinological Society (BRS) Council on where the use of biologic...

Studies of the Role of Basophils in Aspirin Exacerbated Respiratory Disease Pathogenesis.
https://doi.org/10.1016/j.jaci.2021.02.045
The Journal of Allergy and Clinical Immunology; Stevens WW, Staudacher AG et. al.

Apr 5th, 2021 - Aspirin Exacerbated Respiratory Disease (AERD) is characterized by the triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and intolerance to cyclooxygenase-1 (COX-1) enzyme inhibitors. The underlying mechanisms contributing to AER...

High CT values relative to the brainstem differentiate inverted papillomas from nasal p...
https://doi.org/10.1016/j.anl.2021.02.011
Auris, Nasus, Larynx; Sano N, Kikuta S et. al.

Apr 3rd, 2021 - A diagnostic indicator for the differentiation of inverted papillomas (IPs) from inflammatory nasal polyps (NPs) has not been established. This study aimed to evaluate whether CT attenuation values relative to those of the brainstem (relative CT n...

see more →

Guidelines  2 results

European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
https://doi.org/10.4193/Rhin20.600
Rhinology Fokkens WJ, Lund VJ et. al.

Feb 22nd, 2020 - The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and cle...

Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI posit...
https://doi.org/10.1111/all.13599
Allergy Kowalski ML, Agache I et. al.

Sep 14th, 2018 - NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflammatory disorder of the respiratory tract occurring in patients with asthma and/or chronic rhinosinusitis with nasal polyps (CRSwNP), symptoms of which are exacerbated b...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  2,877 results

Microbiome profiling of uncinate tissue and nasal polyps in patients with chronic rhino...
https://doi.org/10.1371/journal.pone.0249688
PloS One; Cho SW, Kim DY et. al.

Apr 8th, 2021 - Chronic rhinosinusitis (CRS) is characterized according to the presence or absence of nasal polyps (NPs) and displays nasal microbiota dysbiosis. However, optimal sampling methods of the nasal microbiome in CRS have not been identified. We aimed t...

Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis.
https://doi.org/10.4193/Rhin20.649
Rhinology Seresirikachorn K, Kerr SJ et. al.

Apr 6th, 2021 - Low-dose macrolides (LDM) are anti-inflammatory agents with antineutrophilic activity, but patient selection for LDM therapy in treating chronic rhinosinusitis (CRS) is controversial. This study aimed to assess factors which predict LDM responders...

British Rhinological Society Consensus Guidance on the use of biological therapies for ...
https://doi.org/10.1111/coa.13779
Clinical Otolaryngology : Official Journal of ENT-UK ; Of... Hopkins C, McKenzie JL et. al.

Apr 5th, 2021 - We set out to create Consensus Guidelines, based on current evidence and relative risks of adverse effects and the costs of different treatments, that reflect the views of the British Rhinological Society (BRS) Council on where the use of biologic...

Studies of the Role of Basophils in Aspirin Exacerbated Respiratory Disease Pathogenesis.
https://doi.org/10.1016/j.jaci.2021.02.045
The Journal of Allergy and Clinical Immunology; Stevens WW, Staudacher AG et. al.

Apr 5th, 2021 - Aspirin Exacerbated Respiratory Disease (AERD) is characterized by the triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and intolerance to cyclooxygenase-1 (COX-1) enzyme inhibitors. The underlying mechanisms contributing to AER...

High CT values relative to the brainstem differentiate inverted papillomas from nasal p...
https://doi.org/10.1016/j.anl.2021.02.011
Auris, Nasus, Larynx; Sano N, Kikuta S et. al.

Apr 3rd, 2021 - A diagnostic indicator for the differentiation of inverted papillomas (IPs) from inflammatory nasal polyps (NPs) has not been established. This study aimed to evaluate whether CT attenuation values relative to those of the brainstem (relative CT n...

see more →

News  93 results

Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease
https://www.medscape.com/viewarticle/946947

Mar 7th, 2021 - NEW YORK (Reuters Health) - Dupilumab, a monoclonal antibody targeting interleukin-4 (IL-4) receptor alpha, should be considered in patients with aspirin-exacerbated respiratory disease (AERD) whose symptoms are not adequately controlled by monocl...

Fast Five Quiz: Sinusitis With Nasal Polyps
https://reference.medscape.com/viewarticle/942877

Dec 28th, 2020 - Chronic rhinosinusitis (CRS) is one of the most common medical disorders worldwide. It is believed to affect nearly 12% of the adult population and is characterized by inflammation of the nose and sinus cavities that persists for a minimum of 12 w...

AstraZeneca's Asthma Drug Succeeds Late-Stage Nasal Polyposis Study
https://www.staging.medscape.com/viewarticle/937161

Sep 10th, 2020 - (Reuters) - AstraZeneca Plc said on Thursday its asthma treatment for a chronic inflammatory disease of the nasal passage linings, or sinuses, met main goals in a late-stage study. The treatment, Fasenra, showed a statistically significant improve...

Lies and Desperation: How, Why 'Professional Study Subjects' Skew Clinical Research
https://www.staging.medscape.com/viewarticle/933869

Jul 13th, 2020 - When a clinical study on asthma launched in late 2019 in Louisiana, Patricia M. (not her real name) signed up. But she was not completely honest about her eligibility. "One of the criteria was you can't have taken prednisone steroids in the past t...

Lies and Desperation: How, Why 'Professional Study Subjects' Skew Clinical Research
https://www.medscape.com/viewarticle/933869

Jul 13th, 2020 - When a clinical study on asthma launched in late 2019 in Louisiana, Patricia M. (not her real name) signed up. But she was not completely honest about her eligibility. "One of the criteria was you can't have taken prednisone steroids in the past t...

see more →

Patient Education  17 results see all →